| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 06/29/2005 | EP1268497B1 Ternary ligand complexes useful as radiopharmaceuticals |
| 06/29/2005 | EP1121425B1 Stabilized bioactive peptides and methods of identification, synthesis and use |
| 06/29/2005 | EP0929574B1 MODULATORS OF beta-AMYLOID PEPTIDE AGGREGATION COMPRISING D-AMINO ACIDS |
| 06/29/2005 | CN1633447A N-formyl peptide receptor complex with a G-protein kinase signal pathway modification agent |
| 06/29/2005 | CN1633446A Novel peptides as NS3-serine protease inhibitors of hepatitis C virus |
| 06/29/2005 | CN1633412A Novel amino acid derivatives, method for production thereof and pharmaceutical compositions comprising said derivative |
| 06/29/2005 | CN1633289A Hemiasterlin derivatives and uses thereof |
| 06/29/2005 | CN1208342C [2-[5-(2-chloropyridineoxy)]methyl] azacyclobutane polypeptide derivative and its application |
| 06/28/2005 | US6911526 Compounds that inhibit the interaction between signal-transducing proteins and the GLGF (PDZ/DHR) domain and uses thereof |
| 06/28/2005 | US6911467 Useful for the treatment of type 2 diabetes, impaired glucose tolerance and certain other conditions |
| 06/28/2005 | US6911431 Pharmaceutical angiostatic dipeptide compositions and methods of use thereof |
| 06/28/2005 | US6911428 Diaryl peptides as NS3-serine protease inhibitors of hepatitis C virus |
| 06/28/2005 | US6911426 Inhibitor of apoptosis proteins (IAP); survivin |
| 06/23/2005 | WO2005056582A1 Ptp1b photoprobes |
| 06/23/2005 | WO2005056580A1 Tetrapeptide regulating blood glucose level in diabetes mellitus |
| 06/23/2005 | WO2005056576A2 Branched peptide amphiphiles, related epitope compounds and self assembled structures thereof |
| 06/23/2005 | WO2005056572A2 Clustered multi-antigenic carbohydrate constructs, methods for their preparation and uses thereof |
| 06/23/2005 | WO2005056551A2 Novel 2-hydroxytetrahydrofurane derivatives and use thereof as medicaments |
| 06/23/2005 | WO2005056519A1 Alpha-ketoamide derivative, and production method and use thereof |
| 06/23/2005 | WO2005056182A1 Removal of ruthenium by-product by supercritical fluid processing |
| 06/23/2005 | US20050137246 Organic amine salts of glutamic acid derivatives and their application |
| 06/23/2005 | US20050137140 Peptidomimetic compounds, useful as antiviral agents |
| 06/23/2005 | US20050137139 Peptidomimetic compounds, useful as antiviral agents; used to inhibit HCV replication and to lessen the risk of or the severity of HCV infection |
| 06/23/2005 | US20050137128 Modulators of ß-amyloid peptide aggregation |
| 06/23/2005 | US20050137127 libraries of macrocyclic peptides used for screening biological targets or drugs; agonists or antagonists of mammal motilin and ghrelin receptors; hormones |
| 06/23/2005 | US20050136474 Truncation SELEX method |
| 06/23/2005 | US20050136042 Methods and compositions for tissue repair |
| 06/23/2005 | CA2549391A1 Branched peptide amphiphiles, related epitope compounds and self assembled structures thereof |
| 06/23/2005 | CA2548448A1 Novel 2-hydroxytetrahydrofurane derivatives and use thereof as medicaments |
| 06/23/2005 | CA2547770A1 Removal of ruthenium by-product by supercritical fluid processing |
| 06/22/2005 | EP1543166A2 Synergistic compositions for the prevention and treatment of acquired immunodeficiency syndrome |
| 06/22/2005 | EP1543145A2 Antifungal therapeutic targets |
| 06/22/2005 | EP1542733A2 Improved method to identify targeting molecules |
| 06/22/2005 | EP1542716A1 Growth hormone releasing peptides |
| 06/22/2005 | CN1629184A N-acyl-aspartic acid-beta-dipeptide derivatives preparing process |
| 06/22/2005 | CN1207303C Active monopeptide prepared from active blood polypeptide and its prepn. activity and sequence |
| 06/22/2005 | CN1207056C Peptide-containing & alpha; -ketoamide cysteine and serine protease inhibitors |
| 06/21/2005 | US6909000 Inhibiting particularly the activity of hepatitis C virus NS3-NS4A protease; peptidomimetics having a bridged bicyclic moiety at the P2 position. |
| 06/21/2005 | US6908919 Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade |
| 06/21/2005 | US6908918 Ketone spirocyclopropaneindene compounds; antineoplastic agents to inhibit tumor cell growth in vitro or in vivo; particularly effective against solid tumors and multi-drug resistant tumors |
| 06/21/2005 | US6908901 Hepatitis C inhibitor peptide analogs |
| 06/21/2005 | US6908899 Pro-inflammatory fibrinopeptide |
| 06/18/2005 | CA2450000A1 Method of creating plants with reduced level of saturated fatty acid in seed oil |
| 06/16/2005 | WO2005054430A2 Hepatitis c virus inhibitors |
| 06/16/2005 | WO2005054288A1 Process for purifying interferon beta |
| 06/16/2005 | WO2005054278A1 Substituted n-benzyl-lactam derivatives as melanocortin-4 receptor agonists |
| 06/16/2005 | WO2005054277A1 Method for synthesis of perindopril and the pharmaceutically-acceptable salts thereof |
| 06/16/2005 | WO2005054276A1 Method for synthesis of perindopril and the pharmaceutically-acceptable salts thereof |
| 06/16/2005 | WO2005054251A1 New cartharidic amine, demethyl cartharidic amine derivatives and their medicinal use |
| 06/16/2005 | WO2005054236A1 Substituted quinolines for the treatment of cancer |
| 06/16/2005 | WO2005054187A1 Methods of preparing compounds useful as protease inhibitors |
| 06/16/2005 | WO2005053735A1 Method of removing transition metals, especially from metathesis reaction products |
| 06/16/2005 | WO2005030135A3 Nitrosated glutamic acid compounds, compositions and methods of use |
| 06/16/2005 | WO2004111192A3 Targeted delivery to legumain-expressing cells |
| 06/16/2005 | WO2004094471A3 Mediators of reverse cholesterol transport for the treatment of hypercholesterolemia |
| 06/16/2005 | WO2000053621A3 Synthetic complementary peptides and ophthalmologic uses thereof |
| 06/16/2005 | US20050130907 N,N'-bis(halophenethyl)aminoalkylamide compounds of given formula as novel pain relievers for cancer or neuropathic pain, or use in cosmetic aftershave or after-sun product; works by inhibiting the vanilloid receptors and show a marginal activity on the NMDA receptor and the neuronal calcium channels |
| 06/16/2005 | US20050130905 Extended storage of reduced glutathione solutions |
| 06/16/2005 | US20050130904 Therapeutic compositions |
| 06/16/2005 | US20050130903 Therapeutic agents and methods of use thereof for the modulation of angiogenesis |
| 06/16/2005 | US20050130902 Upregulate expression of a gene encoding an antioxidative anzyme, such as superoxide dismutase or catalase; neurodegenerative, cardiovascular, cerebral, disorders, trauma, injuries, burns, cancer |
| 06/16/2005 | US20050130883 Serine protease inhibitors |
| 06/16/2005 | US20050130880 zinc(II) organic complex with ligands selected from aminoalkylpyridines, bis-optically active amino acids, bisaminoalkylcarboxylic acids, oligopeptides, oligopseudopeptides, di-substituted aminocarboxylic acids, alpha - and beta -hydroxycarboxylic acids, vitamins, glutamine; insulin mimetics; less toxic; |
| 06/16/2005 | US20050129676 Compounds and methods for modulating functions of classical cadherins |
| 06/16/2005 | CA2547955A1 Methods of preparing compounds useful as protease inhibitors |
| 06/16/2005 | CA2539575A1 Method of removing transition metals, especially from metathesis reaction products |
| 06/15/2005 | EP1541173A1 Method of degrading transcriptional factors of saccharometabolism-associated gene, method of inhibiting the degradation and degradation inhibitor |
| 06/15/2005 | EP1539682A2 Process for the synthesis of intermediates useful for the synthesis of tubulin inhibitors |
| 06/15/2005 | EP1290447B1 Peptide potentiation of acid-sensory ion channel in pain |
| 06/15/2005 | EP1268519B1 Inhibitors of serine proteases, particularly hepatitis c virus ns3 protease |
| 06/15/2005 | EP1072608B1 Glutathione derivatives and dosage forms thereof |
| 06/15/2005 | EP0956031B1 Inhibition of 26 s and 20 s proteasome by indanones |
| 06/15/2005 | CN1206238C N-alkylaspartyldipeptide ester derivatives and sweeteners |
| 06/15/2005 | CN1205995C Hybrid polypeptides with enhanced pharmacokinetic properties |
| 06/14/2005 | US6906245 Introducing nucleotide sequence encoding variant of proto-porphyrinogen IX oxidase lacking FAD binding sequence; expressing and regenerating |
| 06/14/2005 | US6906198 Protease inhibitors; viricides |
| 06/14/2005 | US6906170 Anti-inflammatory peptides derived from IL-2 and analogues thereof |
| 06/14/2005 | US6906056 Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds |
| 06/14/2005 | US6905704 Animal extracts; hypotensive agent; storage stability |
| 06/14/2005 | US6905455 Radioactive member and method of making |
| 06/11/2005 | CA2450540A1 Antimicrobial peptides with reduced hemolysis and methods of their use |
| 06/09/2005 | WO2005051980A1 Depeptidized inhibitors of hepatitis c virus ns3 protease |
| 06/09/2005 | WO2005051978A2 Compounds for delivering amino acids or peptides with antioxidant activity into mitochondria and use thereof |
| 06/09/2005 | WO2005051799A2 Peptide increasing fusiogenic capacity of a gamete |
| 06/09/2005 | WO2005051411A1 Novel drug: oxachelin and its derivatives |
| 06/09/2005 | WO2005051410A1 Hepatitis c virus inhibitors |
| 06/09/2005 | WO2005051367A1 Carboxamide and amino derivatives and methods of their use |
| 06/09/2005 | WO2005040142A9 Novel keto-oxadiazole derivatives as cathepsin inhibitors |
| 06/09/2005 | WO2004101602A3 Hepatitis c inhibitor peptide analogs |
| 06/09/2005 | WO2004098628A3 Synthetic peptide analogs of arg-pro-pro-gly-phe as selective inhibitors of thrombin and thrombin activation of protease activated receptors 1 and 4 |
| 06/09/2005 | US20050124788 Intermediates for lhrh antagonist synthesis, process for their production, and process for lhrh antagonist production |
| 06/09/2005 | US20050124597 Novel guanidinyl derivatives |
| 06/09/2005 | US20050124553 Erectile dysfunction |
| 06/09/2005 | US20050124551 Or its cystine-coupled dimer, mixed with a nonsteroidal antiinflammatory agent used to treat contact dermatitis. |
| 06/09/2005 | US20050124035 Method for producing alpha-L-aspartyl-L-phenylalanine-beta-ester and methd for producing alpha-L-aspartyl-l-phenylalanine-alpha-methyl esther |
| 06/09/2005 | US20050123537 Treating cancer and other angiogenic diseases |
| 06/09/2005 | DE4142157B4 Opioid-Peptide, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zusammensetzung Opioid peptides, process for their preparation and pharmaceutical composition containing the |
| 06/09/2005 | CA2547086A1 Compounds for delivering amino acids or peptides with antioxidant activity into mitochondria and use thereof |
| 06/09/2005 | CA2546498A1 Peptide increasing fusiogenic capacity of a gamete |
| 06/09/2005 | CA2546290A1 Depeptidized inhibitors of hepatitis c virus ns3 protease |